BMS Secures Better HTA Result In Germany With Additional Data for Camzyos

 
• By Francesca Bruce
Germany Heart
BMS' cardiomyopathy drug Camzyos gets upgraded benefit assessment rating in Germany • Source: Shutterstock

More from Europe

More from Geography